Article Text

Download PDFPDF
BET 1: The Ottawa Subarachnoid Hemorrhage Clinical Decision Rule shows high sensitivity but limited evidence of patient benefit
  1. Dorothy Law1,
  2. Robert Hirst2,
  3. Daniel Horner3
  1. 1 Emergency Medicine Resident, Yan Chai Hospital, Hong Kong, Hong Kong
  2. 2 Specialty Trainee, Emergency Medicine, Bristol Royal Infirmary, Bristol, UK
  3. 3 Consultant in Emergency and Critical Care Medicine, Salford Royal NHS Foundation Trust, Salford, UK


A short-cut review of the literature was carried out to examine the diagnostic test characteristics and potential patient benefits through the use of the Ottawa Subarachnoid Haemorrhage Clinical Decision Rule. Nine papers were identified as suitable for inclusion using the reported search strategy. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of the best papers are tabulated. It is concluded that the Ottawa Clinical Decision Rule has a high sensitivity for the diagnosis of subarachnoid haemorrhage; however, there is limited robust evidence of international generalisability and no evidence of improved patient outcomes following implementation. Further prospective research is required in populations with variable prevalence to evaluate the safety and effectiveness of this intervention, compared with routine evaluation strategies.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.